Reaction Details Report a problem with these data
Target
Cytochrome P450 2C19
Ligand
BDBM50134936
Substrate
n/a
Meas. Tech.
ChEMBL_494880 (CHEMBL949430)
IC50
24000±n/a nM
Citation
 O'Neill, PM; Park, BK; Shone, AE; Maggs, JL; Roberts, P; Stocks, PA; Biagini, GA; Bray, PG; Gibbons, P; Berry, N; Winstanley, PA; Mukhtar, A; Bonar-Law, R; Hindley, S; Bambal, RB; Davis, CB; Bates, M; Hart, TK; Gresham, SL; Lawrence, RM; Brigandi, RA; Gomez-delas-Heras, FM; Gargallo, DV; Ward, SA Candidate selection and preclinical evaluation of N-tert-butyl isoquine (GSK369796), an affordable and effective 4-aminoquinoline antimalarial for the 21st century. J Med Chem 52:1408-15 (2010) [PubMed]  Article 
Target
Name:
Cytochrome P450 2C19
Synonyms:
(R)-limonene 6-monooxygenase | (S)-limonene 6-monooxygenase | (S)-limonene 7-monooxygenase | CP2CJ_HUMAN | CYP2C19 | CYPIIC17 | CYPIIC19 | Cytochrome P450 2C19 (CYP2C19) | Cytochrome P450 2C19 [I331V] | Cytochrome P450-11A | Cytochrome P450-254C | Fenbendazole monooxygenase (4'-hydroxylating) | Mephenytoin 4-hydroxylase | P450-11A | P450-254C
Type:
Enzyme
Mol. Mass.:
55935.47
Organism:
Homo sapiens (Human)
Description:
P33261
Residue:
490
Sequence:
MDPFVVLVLCLSCLLLLSIWRQSSGRGKLPPGPTPLPVIGNILQIDIKDVSKSLTNLSKIYGPVFTLYFGLERMVVLHGYEVVKEALIDLGEEFSGRGHFPLAERANRGFGIVFSNGKRWKEIRRFSLMTLRNFGMGKRSIEDRVQEEARCLVEELRKTKASPCDPTFILGCAPCNVICSIIFQKRFDYKDQQFLNLMEKLNENIRIVSTPWIQICNNFPTIIDYFPGTHNKLLKNLAFMESDILEKVKEHQESMDINNPRDFIDCFLIKMEKEKQNQQSEFTIENLVITAADLLGAGTETTSTTLRYALLLLLKHPEVTAKVQEEIERVIGRNRSPCMQDRGHMPYTDAVVHEVQRYIDLIPTSLPHAVTCDVKFRNYLIPKGTTILTSLTSVLHDNKEFPNPEMFDPRHFLDEGGNFKKSNYFMPFSAGKRICVGEGLARMELFLFLTFILQNFNLKSLIDPKDLDTTPVVNGFASVPPFYQLCFIPV
  
Inhibitor
Name:
BDBM50134936
Synonyms:
2-(tert-Butylamino-methyl)-5-(7-chloro-quinolin-4-ylamino)-phenol | CHEMBL147806 | N-tert-Butyl isoquine
Type:
Small organic molecule
Emp. Form.:
C20H22ClN3O
Mol. Mass.:
355.861
SMILES:
CC(C)(C)NCc1ccc(Nc2ccnc3cc(Cl)ccc23)cc1O
Structure:
Search PDB for entries with ligand similarity: